RYR2 and cardiac rhythm disease: A more specific 1,4-benzothiazepine derivative, which in the rodent model enhanced the binding of calstabin2 to the mutant RyR2-R2474S channel, inhibited the channel leak and prevented cardiac arrhythmias (Lehnart et al., 2008).